BioSpace News Archive

NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, and OnRamp Bioinformatics, a provider of cloud-based genomic analysis tools, today announced a collaboration for the development of new analysis tools for data generated on NanoString’s nCounter® Analysis

Phase 3, multicenter U.S. clinical trial utilizing Octagam ® 10% will start immediately to evaluate if high-dose IVIG can stabilize or improve patient clinical status PARAMUS, N.J.--( BUSINESS WIRE )-- The U.S. Food and Drug Administration (FDA) has approved the investigational new drug (IND) application submitted by Octapharma USA for a phase three clinical trial on the efficacy and safety of Octagam ® 10% [Immune Globulin Intravenous (Human)] ther

The ongoing COVID-19 pandemic is having a significant impact on medical students. As universities have shifted to virtual learning models and online classes, students have had to shift their learning and study habits.

Licensed phlebotomists will drive to patients’ locations, including homes and offices, to collect blood and other specimen samples needed by researchers Initiative expands iSpecimen’s mission of streamlining human biospecimen collection for medical research [20-May-2020] LEXINGTON, Mass. , May 20, 2020 /PRNewswire/ -- iSpecimen today announced a new initia

A New Strategic Alliance Between BIOTRONIK, A Leader In Cardiac Rhythm Management, and Acutus Medical, Electrophysiology Innovator, Expected to Offer More Efficient and Effective Diagnosis and Treatment for Arrhythmia Patients [20-May-2020] CARLSBAD, Calif. and BERLIN , May 20, 2020 /PRNewswire/ -- Acutus Medical and BIOTRONIK today announced a new alliance to p

A new study released as part of the American Academy of Orthopaedic Surgeons’ Virtual Education Experience determined that despite increased awareness of concussions in high school athletics and traumatic brain injury laws, the incidence continues to rise.

Innate Pharma SA announces the results of the vote of its shareholders at the Annual General Meeting which took place on May 19, 2020, in Marseille, France without the physical presence of its shareholders.

Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, announced that the Company’s novel IgG-degrading enzyme, imlifidase, will be highlighted in three presentations including a late breaking poster presentation at the upcoming 2020 American Transplant Congress, on May 30 to June 1, 2020.

Life sciences and microbiome knowledge discovery company Eagle Genomics announced that Cargill has signed a multi-year platform agreement to enable the digital transformation of microbiome and life sciences R&D across its global locations.

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers, announced the closing of a $20 million Series A financing of Zentera Therapeutics, a biopharmaceutical company with headquarters in Shanghai, China.